The California Stem Cell Report will
provide live, gavel-to-gavel coverage of tomorrow's session of the
governing board of the $3 billion California stem cell agency from
the meeting location in La Jolla, Ca.
On the agenda is a $14.3 million award
to Asterias Therapeutics to continue the hESC clinical trial begun by
Geron. Directors are scheduled to receive an update on CIRM finances.
The agency is scheduled to run out of money for new awards in 2017
and is attempting to find new sources of funding.
For those who want to listen to the
daylong meeting on the Internet, instructions can be found on the meeting agenda. A live teleconference location is also available in
San Francisco. The address can be found also on the agenda.
No comments:
Post a Comment